Literature DB >> 24100560

Cloning, overexpression, purification, crystallization and preliminary X-ray diffraction analysis of Rv0241c (HtdX) from Mycobacterium tuberculosis H37Rv.

Rupam Biswas1, Debajyoti Dutta, Amit Kumar Das.   

Abstract

Rv0241c (HtdX) is a putative (3R)-hydroxyacyl-CoA dehydratase of Mycobacterium tuberculosis. The htdX gene belongs to a conserved operon and is expressed in mycobacteria in the presence of several fatty-acid synthase II drugs. To elucidate the structure of HtdX, the protein was cloned, overexpressed, purified to homogeneity and crystallized. The protein was crystallized from two conditions: (i) 3 M sodium chloride, 0.1 M Na HEPES pH 8.0 and (ii) 2.5 M sodium chloride, 0.1 M Tris-HCl pH 8.5. A complete diffraction data set was collected from crystals from both conditions. The crystal from the first condition diffracted to 2.3 Å resolution and belonged to space group I41, with unit-cell parameters a=b=61.51, c=143.81 Å. Crystals from the second condition diffracted to 3.1 Å resolution and belonged to space group P4₃2₁2 or P4₁2₁2, with unit-cell parameters a=b=63.67, c=140.88 Å. Both crystals contained one molecule in the asymmetric unit.

Entities:  

Keywords:  Mycobacterium tuberculosis; Rv0241c (HtdX)

Mesh:

Substances:

Year:  2013        PMID: 24100560      PMCID: PMC3792668          DOI: 10.1107/S1744309113023452

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  32 in total

Review 1.  Structural and functional organization of the animal fatty acid synthase.

Authors:  Stuart Smith; Andrzej Witkowski; Anil K Joshi
Journal:  Prog Lipid Res       Date:  2003-07       Impact factor: 16.195

2.  The solution structure of acyl carrier protein from Mycobacterium tuberculosis.

Authors:  Hing C Wong; Gaohua Liu; Yong-Mei Zhang; Charles O Rock; Jie Zheng
Journal:  J Biol Chem       Date:  2002-02-01       Impact factor: 5.157

3.  Biochemical characterization of acyl carrier protein (AcpM) and malonyl-CoA:AcpM transacylase (mtFabD), two major components of Mycobacterium tuberculosis fatty acid synthase II.

Authors:  L Kremer; K M Nampoothiri; S Lesjean; L G Dover; S Graham; J Betts; P J Brennan; D E Minnikin; C Locht; G S Besra
Journal:  J Biol Chem       Date:  2001-05-23       Impact factor: 5.157

4.  7.5-Å cryo-em structure of the mycobacterial fatty acid synthase.

Authors:  Daniel Boehringer; Nenad Ban; Marc Leibundgut
Journal:  J Mol Biol       Date:  2013-01-03       Impact factor: 5.469

5.  Crystal structure of hexanoyl-CoA bound to β-ketoacyl reductase FabG4 of Mycobacterium tuberculosis.

Authors:  Debajyoti Dutta; Sudipta Bhattacharyya; Amlan Roychowdhury; Rupam Biswas; Amit Kumar Das
Journal:  Biochem J       Date:  2013-02-15       Impact factor: 3.857

6.  Structure and conformational variability of the mycobacterium tuberculosis fatty acid synthase multienzyme complex.

Authors:  Luciano Ciccarelli; Sean R Connell; Mathias Enderle; Deryck J Mills; Janet Vonck; Martin Grininger
Journal:  Structure       Date:  2013-06-06       Impact factor: 5.006

7.  Crystal structure of FabG4 from Mycobacterium tuberculosis reveals the importance of C-terminal residues in ketoreductase activity.

Authors:  Debajyoti Dutta; Sudipta Bhattacharyya; Somnath Mukherjee; Baisakhee Saha; Amit Kumar Das
Journal:  J Struct Biol       Date:  2010-11-21       Impact factor: 2.867

8.  MabA (FabG1), a Mycobacterium tuberculosis protein involved in the long-chain fatty acid elongation system FAS-II.

Authors:  Hedia Marrakchi; Stéphanie Ducasse; Gilles Labesse; Henri Montrozier; Emmanuel Margeat; Laurent Emorine; Xavier Charpentier; Mamadou Daffé; Annaı K Quémard
Journal:  Microbiology (Reading)       Date:  2002-04       Impact factor: 2.777

9.  Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.

Authors:  M L Schaeffer; G Agnihotri; C Volker; H Kallender; P J Brennan; J T Lonsdale
Journal:  J Biol Chem       Date:  2001-10-12       Impact factor: 5.157

10.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more
  1 in total

1.  Advance in Research on Mycobacterium tuberculosis FabG4 and Its Inhibitor.

Authors:  Debajyoti Dutta
Journal:  Front Microbiol       Date:  2018-06-06       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.